Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
214.50    0.00 (0.00%)
Bid:
211.00
Ask:
218.00
Spread: 7.00 (3.318%)
Market Cap: £146.49m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

2023 Helios Retained Capacity Update

10 Jan 2023 07:00

RNS Number : 1574M
Helios Underwriting Plc
10 January 2023
 

10th January 2023

 

Helios Underwriting plc

("Helios" or the "Company")

 

2023 Helios Retained Capacity Update

 

Portfolio increased by 27% year-on-year to £297 million

 

Helios, the unique investment vehicle that acquires and consolidates underwriting capacity at Lloyds', announces an update on the Company's capacity to be underwritten for 2023.

 

 Nigel Hanbury, Chief Executive of Helios, commented:

 

"I am delighted that the retained capacity underwritten by Helios shareholders will have significantly increased for another successive underwriting year to £238m. Market discipline remains strong and we are confident that 2023 will offer superior returns. The January renewals supports this with significant pricing improvement and market dislocation in the reinsurance and retro markets respectively. Rating indices across most lines are at or above our underwriting requirements and the Board is confident the Company is well positioned to maximise market opportunities."

 

Capacity Update

Helios announces that the retained underwriting capacity for the 2023 year of account will be £238m, a near 40% increase in the capacity underwritten since the start of 2022. The overall portfolio, including the capacity reinsured, has increased to £297m, adding more than 27% to the size of the portfolio since the 1st January 2022.

 

Helios - 2023 Year of Account Capacity

£m

Retained

Reinsured

Total

Capacity as at 1st January 2023

238.3

58.3

296.6

Capacity as at 1st January 2022

171.1

61.6

232.7

% change - Increase/(Decrease)

39%

(5)%

27%

 

The prospects for underwriting profitability and higher investment returns have improved considerably and the Board believes this substantial increase in the retained capacity will significantly benefit the Company's shareholders for 2023 onwards. 

 

The analysis of this increase in the Helios portfolio is as follows:

Capacity

 

£m

Capacity at 1st January 2021 for 2022 YOA

232.7

Capacity acquired in 2022 for 2023 YOA

5.7

Pre-emption capacity

36.0

Disposal of capacity in the capacity auction

(16.7)

Additions to Tenancy Capacity 

38.9

Capacity as at 1st January 2023 for 2023 YOA

 

296.6

Helios has and continues to support both new and well established syndicates that offer capacity for a limited period only, referred to as Tenancy Capacity, and Helios expects to support these syndicates in the longer term. 

 

Helios acquired three LLVs in 2022 adding £5.7m of capacity to the 2022 year of account and increased the retained capacity for all three open years of account.

 

The split of capacity between retained and reinsured for the current open years of account is currently as follows:

 

Retained Capacity 2020 to 2023 Years of Account

 

 

2020

2021

2022

2023

 

£m

£m

£m

£m

Capacity - Position as at 1st January 2022

66.5

93.4

171.1

-

Capacity acquired during 2022

5.6

5.8

5.7

-

Capacity - Expected at 1st January 2023

72.1

99.2

176.8

238.3

 

The increased retained capacity on the 2020 to 2022 years of account, substantially "off-risk" for the underwriting years, will contribute to the recognised profits in the future.

 

Split of Freehold and Leasehold Capacity by Year of Account

As at 1st January - £m

2022 YOA

2023 YOA

Freehold capacity

144.8

147.3

Tenancy capacity

87.9

149.3

Total capacity

232.7

296.6

Value of capacity Fund

59.8

60.0

 

For further information please contact:

 

Helios Underwriting plc

Nigel Hanbury - Chief Executive +44 (0)7787 530 404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer +44 (0)7754 965 917

 

Shore Capital (Nomad and Broker)

Robert Finlay +44 (0)20 7601 6100

David Coaten

 

Buchanan (PR)

Helen Tarbet / Henry Wilson / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £297m of capacity for the 2023 account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCVKLFBXFLFBBZ
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20264:05 pmRNSGrant of LTIP Award
5th Jun 20267:00 amRNSGrant of LTIP Awards
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSFinal Results for the year ended 31 December 2025
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTR-1 announcement
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTR-1: Acquisition of Voting Rights
21st Apr 20267:00 amRNSChange of Nominated Adviser
20th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20265:17 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSQuarterly Syndicate Mid-point Forecast update
20th Jan 20267:00 amRNS2026 YOA Portfolio Update
9th Jan 20267:00 amRNSAppointment of Chief Underwriting Officer
4th Dec 20255:42 pmRNSGrant of LTIP Awards
2nd Dec 20257:00 amRNSNet Asset Value(s)
13th Nov 20251:32 pmRNSDirector/PDMR Shareholding
13th Nov 20251:30 pmRNSDirector/PDMR Shareholding
7th Nov 202510:10 amRNSHolding(s) in Company
6th Nov 20251:51 pmRNSDirector/PDMR Shareholding
5th Nov 20255:48 pmRNSTR1 - Change in breakdown of voting rights
30th Oct 20257:00 amRNSResult of Tender Offer
24th Oct 202512:20 pmRNSResults of General Meeting
21st Oct 20257:01 amRNSDirector Appointments
21st Oct 20257:00 amRNSCapital Markets Day
29th Sep 20257:01 amRNSProposed Tender Offer and Notice of GM
29th Sep 20257:00 amRNSHalf Year Results
19th Sep 20257:00 amRNSAppointment of Chief Executive Officer
1st Sep 20253:37 pmRNSDirector/PDMR Shareholding
29th Aug 202512:52 pmRNSPDMR Dealing
28th Aug 20252:16 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSQuarterly Syndicate Mid-point Forecasts
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202512:12 pmRNSTR-1: Notification of major holdings
18th Jul 20257:00 amRNSResults of Scrip Dividend Election
9th Jul 20259:45 amRNSResults of Scrip Dividend Election
30th Jun 20255:40 pmRNSAppointment of Executive Director
30th Jun 202512:28 pmRNSResult of AGM
30th Jun 20257:00 amRNSChange of Nominated Adviser
20th Jun 20259:32 amRNSScrip Dividend Reference Price
9th Jun 20251:15 pmRNSLTIP Exercise and Total Voting Rights Update
9th Jun 20251:15 pmRNSGrant of LTIP Awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.